Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program

Fertility and Sterility

Volumn 70, Issue 6, 1998, Pages 1035-1038

  Lass, Amir ^a   Ellenbogen, Adrian ^a   Croucher, Carolyn ^a   Trew, Geoff ^a   Margara, Raul ^a   Becattini, Carolina ^a   Winston, Robert M L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

GnRH agonist; IVF; Ovary; Ovulation induction; Salpingectomy

Indexed keywords

BUSERELIN; BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; PROGESTERONE; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; ECTOPIC PREGNANCY; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVAGINAL DRUG ADMINISTRATION; OOCYTE DEVELOPMENT; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION INDUCTION; PREGNANCY RATE; PRIORITY JOURNAL; SALPINGECTOMY; TREATMENT OUTCOME;

ADULT; BUSERELIN; CHORIONIC GONADOTROPIN; EMBRYO TRANSFER; FALLOPIAN TUBES; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; OVARY; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; RECEPTORS, LHRH; SUPEROVULATION;

EID: 0032403598     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(98)00357-4     Document Type: Article

References (19)

1. Dubuisson J.B., Morice P., Chapron C., De Gayffier A., Mouelhi T. Salpingectomy the laparoscopic surgical choice for ectopic pregnancy . Hum Reprod. 11:1996;1199-1203.
2. Dubuisson J.B., Aubriot F.X., Mathieu L., Foulot H., Mandelbrot L., de Joliniere J.B. Risk factors for ectopic pregnancy in 556 pregnancies after in vitro fertilization implications for preventive management . Fertil Steril. 56:1991;686-690.
3. Shelton K.E., Butler L., Toner J.P., Oehninger S., Muasher S.J. Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx. Hum Reprod. 11:1996;523-525.
4. Andersen A.N., Yue Z., Meng F.J., Person K. Low implantation rate after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod. 9:1994;1935-1938.
5. Vandromme J., Chasse B.L., Van Rysselberge M., Delvigne A., Leroy F. Hydrosalpinges in in-vitro fertilization an unfavourable prognostic feature . Hum Reprod. 10:1995;576-579.
6. Katz E., Akman M.A., Damewood M.D., Garcia J.E. Deleterious effect of the presence of hydrosalpinx on implantation and pregnancy rates with in-vitro fertilization. Fertil Steril. 66:1996;122-125.
7. Strandell A., WaldenstrÖm U., Nilsson L., Hamberger L. Hydrosalpinx reduces in-vitro fertilization/embryo transfer pregnancy rates. Hum Reprod. 4:1994;861-863.
8. Blazer A.S., Hogan J.W., Seifer D.B., Frishman G.N., Wheeler C.A., Haning R.V. The impact of hydrosalpinx on successful pregnancy in tubal factor infertility treated by in-vitro fertilization. Fertil Steril. 67:1997;517-519.
9. Mukherjee T., Copperman A.B., McCarffrey C., Cook C.A., Bustillo M., Obassaju M.F. Hydrosalpinx fluid has embryotoxic effects on murine embryogenesis a case for prophylactic salpingectomy . Fertil Steril. 66:1996;851-853.
10. Andersen A.N., Lindhard A., Loft A., Ziebe S., Andersen C.Y. The infertile patient with hydrosalpinges IVF with or without salpingectomy? Hum Reprod. 11:1996;2081-2084.
11. Romeu A, Steingold K, Jones D, Acosta AA. Significance of bilateral salpingectomy in the outcome of IVF-ET. Proceedings of the Fifth World Congress on In Vitro Fertilization and Embryo Transfer; 1987 April 5-10; Norfolk, VA. Birmingham, AL: American Fertility Society, 1997:87.
12. Oehninger S., Scott R., Muasher S.J., Acosta A.A., Jones H.W. Jr, Rosenwaks Z. Effects of the severity of tubo-ovarian disease and previous tubal surgery on the results of in vitro fertilization and embyro transfer. Fertil Steril. 51:1989;126-130.
13. Verhulst G., Vandersteen N., Van Steirteghem A.C., Devroey P. Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme. Hum Reprod. 9:1994;624-628.
14. Rutherford A.J., Subak-Sharpe R.J., Dawson K.J., Margara R.A., Franks S., Winston R.M. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone. Br Med J. 25:1988;296-302.
15. Lass A., Skull J., McVeigh E., Margara R., Winston R.M.L. Measurement of ovarian volume by transvaginal sonography before ovulation induction with human menopausal gonadotropin for in-vitro fertilization can predict poor response. Hum Reprod. 12:1997;294-297.
16. Beyth Y., Winston R.M.L. Ovum capture and fertility following microsurgical fimbriectomy in the rabbit. Fertil Steril. 35:1981;464-466.
17. McComb P., Delbeke L. Decreasing the number of ovulations in the rabbit with surgical division of the blood vessels between the fallopian tube and ovary. J Reprod Med. 29:1984;827-829.
18. Shelton K., Butler L., Toner J.P., Oehninger S., Muasher S.J. Salpingectomy improves the pregnancy rate in in-vitro fertilization patients with hydrosalpinx. Hum Reprod. 11:1996;523-525.
19. Lass A., Paul M., Margara R., Winston R.M.L. Women with one ovary have decreased response to GnRHa/hMG ovulation induction protocol in IVF but the same pregnancy rate as women with two ovaries. Hum Reprod. 12:1997;298-300.